

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.27182930 |
| 2 | chaperone-mediated protein transport (GO:0072321) | 6.00306451 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.89510198 |
| 4 | DNA deamination (GO:0045006) | 5.85320868 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.44477797 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.44477797 |
| 7 | respiratory electron transport chain (GO:0022904) | 5.35726331 |
| 8 | electron transport chain (GO:0022900) | 5.24238794 |
| 9 | protein complex biogenesis (GO:0070271) | 5.02515245 |
| 10 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.97980918 |
| 11 | NADH dehydrogenase complex assembly (GO:0010257) | 4.97980918 |
| 12 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.97980918 |
| 13 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.53914859 |
| 14 | proteasome assembly (GO:0043248) | 4.35883970 |
| 15 | protein neddylation (GO:0045116) | 4.30894019 |
| 16 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.27366533 |
| 17 | behavioral response to nicotine (GO:0035095) | 4.26843752 |
| 18 | respiratory chain complex IV assembly (GO:0008535) | 4.25797947 |
| 19 | gamma-aminobutyric acid transport (GO:0015812) | 4.16557031 |
| 20 | inner mitochondrial membrane organization (GO:0007007) | 4.05926682 |
| 21 | protein deneddylation (GO:0000338) | 4.01794294 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.97016268 |
| 23 | maturation of 5.8S rRNA (GO:0000460) | 3.91031453 |
| 24 | dopamine transport (GO:0015872) | 3.89183217 |
| 25 | 7-methylguanosine mRNA capping (GO:0006370) | 3.87612623 |
| 26 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.80436656 |
| 27 | GTP biosynthetic process (GO:0006183) | 3.77153130 |
| 28 | 7-methylguanosine RNA capping (GO:0009452) | 3.77102874 |
| 29 | RNA capping (GO:0036260) | 3.77102874 |
| 30 | cytochrome complex assembly (GO:0017004) | 3.76621826 |
| 31 | positive regulation of mitochondrial fission (GO:0090141) | 3.68325065 |
| 32 | cullin deneddylation (GO:0010388) | 3.56630057 |
| 33 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.54391987 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.53814482 |
| 35 | protein targeting to mitochondrion (GO:0006626) | 3.53070783 |
| 36 | neuron cell-cell adhesion (GO:0007158) | 3.52540236 |
| 37 | aerobic respiration (GO:0009060) | 3.48678086 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.43658419 |
| 39 | termination of RNA polymerase III transcription (GO:0006386) | 3.43092075 |
| 40 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.43092075 |
| 41 | nucleobase catabolic process (GO:0046113) | 3.42794551 |
| 42 | hydrogen ion transmembrane transport (GO:1902600) | 3.40791295 |
| 43 | establishment of protein localization to mitochondrion (GO:0072655) | 3.39761599 |
| 44 | nonmotile primary cilium assembly (GO:0035058) | 3.39723515 |
| 45 | oxidative phosphorylation (GO:0006119) | 3.39490423 |
| 46 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.38678308 |
| 47 | rRNA modification (GO:0000154) | 3.36319923 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.35277496 |
| 49 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.33729570 |
| 50 | protein localization to cilium (GO:0061512) | 3.33333210 |
| 51 | transmission of nerve impulse (GO:0019226) | 3.33194084 |
| 52 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.30968638 |
| 53 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.29230071 |
| 54 | regulation of mitochondrial translation (GO:0070129) | 3.28614339 |
| 55 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25909155 |
| 56 | protein localization to mitochondrion (GO:0070585) | 3.25231932 |
| 57 | amino acid salvage (GO:0043102) | 3.24036498 |
| 58 | L-methionine salvage (GO:0071267) | 3.24036498 |
| 59 | L-methionine biosynthetic process (GO:0071265) | 3.24036498 |
| 60 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.22376100 |
| 61 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.22376100 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.22008332 |
| 63 | protein-cofactor linkage (GO:0018065) | 3.17732188 |
| 64 | synaptic vesicle maturation (GO:0016188) | 3.16827855 |
| 65 | platelet dense granule organization (GO:0060155) | 3.16516758 |
| 66 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.15253616 |
| 67 | negative regulation of ligase activity (GO:0051352) | 3.15253616 |
| 68 | iron-sulfur cluster assembly (GO:0016226) | 3.13914844 |
| 69 | metallo-sulfur cluster assembly (GO:0031163) | 3.13914844 |
| 70 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.11068178 |
| 71 | detection of light stimulus involved in visual perception (GO:0050908) | 3.11068178 |
| 72 | proton transport (GO:0015992) | 3.10289943 |
| 73 | response to misfolded protein (GO:0051788) | 3.09900789 |
| 74 | transferrin transport (GO:0033572) | 3.09761331 |
| 75 | UTP biosynthetic process (GO:0006228) | 3.08847975 |
| 76 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.08668820 |
| 77 | ribosomal small subunit assembly (GO:0000028) | 3.07223642 |
| 78 | glycosphingolipid biosynthetic process (GO:0006688) | 3.06971429 |
| 79 | hydrogen transport (GO:0006818) | 3.05972355 |
| 80 | presynaptic membrane organization (GO:0097090) | 3.04935974 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04928480 |
| 82 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.04784027 |
| 83 | behavioral response to ethanol (GO:0048149) | 3.02662887 |
| 84 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.02636643 |
| 85 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02399080 |
| 86 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00011339 |
| 87 | glutamate receptor signaling pathway (GO:0007215) | 2.99986486 |
| 88 | ribosomal small subunit biogenesis (GO:0042274) | 2.98452093 |
| 89 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.97981899 |
| 90 | regulation of cilium movement (GO:0003352) | 2.97307883 |
| 91 | response to pheromone (GO:0019236) | 2.96647390 |
| 92 | rRNA methylation (GO:0031167) | 2.96218698 |
| 93 | neuron-neuron synaptic transmission (GO:0007270) | 2.95937882 |
| 94 | synaptic transmission, glutamatergic (GO:0035249) | 2.91608102 |
| 95 | ATP biosynthetic process (GO:0006754) | 2.89101874 |
| 96 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.88814389 |
| 97 | intracellular protein transmembrane import (GO:0044743) | 2.87821570 |
| 98 | vocalization behavior (GO:0071625) | 2.87324521 |
| 99 | neurofilament cytoskeleton organization (GO:0060052) | 2.86756184 |
| 100 | quinone biosynthetic process (GO:1901663) | 2.85577181 |
| 101 | ubiquinone biosynthetic process (GO:0006744) | 2.85577181 |
| 102 | cellular ketone body metabolic process (GO:0046950) | 2.84813683 |
| 103 | NADH metabolic process (GO:0006734) | 2.84278615 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.83307229 |
| 105 | cellular component biogenesis (GO:0044085) | 2.83232259 |
| 106 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.83053397 |
| 107 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.83053397 |
| 108 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.83053397 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.82729456 |
| 110 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82263609 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.82210099 |
| 112 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.82153268 |
| 113 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.82153268 |
| 114 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.81189874 |
| 115 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.81189874 |
| 116 | ferric iron transport (GO:0015682) | 2.79979590 |
| 117 | trivalent inorganic cation transport (GO:0072512) | 2.79979590 |
| 118 | axoneme assembly (GO:0035082) | 2.78791679 |
| 119 | startle response (GO:0001964) | 2.78517883 |
| 120 | ribosomal large subunit biogenesis (GO:0042273) | 2.78055033 |
| 121 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.77602562 |
| 122 | neural tube formation (GO:0001841) | 2.77377023 |
| 123 | indolalkylamine metabolic process (GO:0006586) | 2.77128433 |
| 124 | retinal cone cell development (GO:0046549) | 2.76453966 |
| 125 | anterograde synaptic vesicle transport (GO:0048490) | 2.76342526 |
| 126 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.76077840 |
| 127 | neuronal action potential (GO:0019228) | 2.74332956 |
| 128 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.73475176 |
| 129 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.73475176 |
| 130 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.73435624 |
| 131 | CTP metabolic process (GO:0046036) | 2.73008221 |
| 132 | CTP biosynthetic process (GO:0006241) | 2.73008221 |
| 133 | positive regulation of ligase activity (GO:0051351) | 2.72838016 |
| 134 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.72812572 |
| 135 | piRNA metabolic process (GO:0034587) | 2.72779522 |
| 136 | establishment of protein localization to Golgi (GO:0072600) | 2.72441833 |
| 137 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.72247096 |
| 138 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.71811310 |
| 139 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.71329543 |
| 140 | adaptation of signaling pathway (GO:0023058) | 2.70460737 |
| 141 | regulation of cellular amine metabolic process (GO:0033238) | 2.69825152 |
| 142 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.69287334 |
| 143 | indole-containing compound catabolic process (GO:0042436) | 2.67676227 |
| 144 | indolalkylamine catabolic process (GO:0046218) | 2.67676227 |
| 145 | tryptophan catabolic process (GO:0006569) | 2.67676227 |
| 146 | UTP metabolic process (GO:0046051) | 2.66787559 |
| 147 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.66745935 |
| 148 | reflex (GO:0060004) | 2.66394982 |
| 149 | regulation of mitochondrial fission (GO:0090140) | 2.64867830 |
| 150 | protein polyglutamylation (GO:0018095) | 2.64502028 |
| 151 | protein localization to synapse (GO:0035418) | 2.63673669 |
| 152 | serotonin metabolic process (GO:0042428) | 2.63535233 |
| 153 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.62143130 |
| 154 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.59883235 |
| 155 | cotranslational protein targeting to membrane (GO:0006613) | 2.59849988 |
| 156 | anterograde axon cargo transport (GO:0008089) | 2.55806962 |
| 157 | regulation of synapse structural plasticity (GO:0051823) | 2.55064903 |
| 158 | postsynaptic membrane organization (GO:0001941) | 2.54134965 |
| 159 | neurotransmitter secretion (GO:0007269) | 2.54043085 |
| 160 | cilium morphogenesis (GO:0060271) | 2.53710748 |
| 161 | protein targeting to Golgi (GO:0000042) | 2.52150126 |
| 162 | regulation of neurotransmitter uptake (GO:0051580) | 2.50298351 |
| 163 | ketone body metabolic process (GO:1902224) | 2.49072345 |
| 164 | inositol phosphate catabolic process (GO:0071545) | 2.46471021 |
| 165 | epithelial cilium movement (GO:0003351) | 2.46416526 |
| 166 | protein localization to Golgi apparatus (GO:0034067) | 2.45939446 |
| 167 | indole-containing compound metabolic process (GO:0042430) | 2.44360315 |
| 168 | DNA double-strand break processing (GO:0000729) | 2.44309864 |
| 169 | righting reflex (GO:0060013) | 2.44200441 |
| 170 | photoreceptor cell maintenance (GO:0045494) | 2.42724447 |
| 171 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.42450134 |
| 172 | membrane depolarization during action potential (GO:0086010) | 2.41593677 |
| 173 | adult walking behavior (GO:0007628) | 2.41498434 |
| 174 | brain morphogenesis (GO:0048854) | 2.41200214 |
| 175 | primary amino compound metabolic process (GO:1901160) | 2.41051476 |
| 176 | regulation of feeding behavior (GO:0060259) | 2.40796291 |
| 177 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.40414499 |
| 178 | synapse assembly (GO:0007416) | 2.39744999 |
| 179 | synaptic vesicle exocytosis (GO:0016079) | 2.39584675 |
| 180 | signal peptide processing (GO:0006465) | 2.39160226 |
| 181 | synaptic transmission, cholinergic (GO:0007271) | 2.38352549 |
| 182 | positive regulation of meiosis (GO:0045836) | 2.38324072 |
| 183 | regulation of action potential (GO:0098900) | 2.37147135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.84911014 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.98494997 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.97358764 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.92066375 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.89061699 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.78827449 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.25023431 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.24544635 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.14830321 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.02085857 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.92214798 |
| 12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.76901296 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.70206358 |
| 14 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.67736387 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.62710824 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46829753 |
| 17 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.35071170 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31987941 |
| 19 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.28444871 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.15113653 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12469350 |
| 22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.11037504 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06125768 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05269605 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00235321 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.90356613 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.89590903 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83332049 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80741647 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77478246 |
| 31 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.73233488 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.73173968 |
| 33 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.72782606 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71715611 |
| 35 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.70286000 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68998314 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68871597 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.68461382 |
| 39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.67158578 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64564489 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60059421 |
| 42 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.58794973 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58446672 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57194368 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55308527 |
| 46 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.54724260 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54093074 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54082735 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.53549631 |
| 50 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.53189131 |
| 51 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.52700158 |
| 52 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.52561706 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50564748 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50335839 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48304064 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47746208 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47492951 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47292779 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46934700 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.45368654 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45291300 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42998511 |
| 63 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.42349056 |
| 64 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42349056 |
| 65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42138004 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41849425 |
| 67 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.41241661 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.40751833 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40305223 |
| 70 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.39835747 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38536757 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38372982 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37576345 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37027346 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36965420 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36267226 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35672286 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35589388 |
| 79 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.34248010 |
| 80 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.34164354 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33963364 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32242818 |
| 83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31825407 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31362450 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31310117 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.31310117 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.30473286 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28067009 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27627504 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26338017 |
| 91 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25788342 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23806084 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23532214 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22675959 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22607163 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22274070 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21846286 |
| 98 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21662423 |
| 99 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21429841 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21333491 |
| 101 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21236360 |
| 102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21048695 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19967103 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19544467 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18833158 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18584425 |
| 107 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18513410 |
| 108 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17494037 |
| 109 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17245539 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.17060799 |
| 111 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16195000 |
| 112 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16195000 |
| 113 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.16134470 |
| 114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15721477 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15720484 |
| 116 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15004187 |
| 117 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.14554186 |
| 118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13931741 |
| 119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11745817 |
| 120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10757730 |
| 121 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10313847 |
| 122 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09996905 |
| 123 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09996905 |
| 124 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09602084 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08668920 |
| 126 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08643833 |
| 127 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07304640 |
| 128 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06736092 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05812365 |
| 130 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05412301 |
| 131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05148400 |
| 132 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04607828 |
| 133 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03150913 |
| 134 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02153221 |
| 135 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01235604 |
| 136 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98707774 |
| 137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98628667 |
| 138 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97775513 |
| 139 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97349853 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97166339 |
| 141 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96127549 |
| 142 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94314215 |
| 143 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92808438 |
| 144 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92407101 |
| 145 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91452366 |
| 146 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89071087 |
| 147 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88975685 |
| 148 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.88900370 |
| 149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88625193 |
| 150 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.88172610 |
| 151 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.84425440 |
| 152 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84376606 |
| 153 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84063447 |
| 154 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.84046173 |
| 155 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82827641 |
| 156 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82235111 |
| 157 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81129787 |
| 158 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.80150058 |
| 159 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.79749905 |
| 160 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.78244590 |
| 161 | JUN_21703547_ChIP-Seq_K562_Human | 0.78019213 |
| 162 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.77622416 |
| 163 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.75368681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001529_abnormal_vocalization | 4.13818372 |
| 2 | MP0003880_abnormal_central_pattern | 3.63423594 |
| 3 | MP0001905_abnormal_dopamine_level | 3.22624944 |
| 4 | MP0003787_abnormal_imprinting | 2.95722199 |
| 5 | MP0005451_abnormal_body_composition | 2.78072049 |
| 6 | MP0002736_abnormal_nociception_after | 2.72553356 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.66303015 |
| 8 | MP0003718_maternal_effect | 2.59546333 |
| 9 | MP0005646_abnormal_pituitary_gland | 2.53089962 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.49595156 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.33675119 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.24030965 |
| 13 | MP0003195_calcinosis | 2.21755530 |
| 14 | MP0004270_analgesia | 2.09820149 |
| 15 | MP0010386_abnormal_urinary_bladder | 2.07003759 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.02706519 |
| 17 | MP0001188_hyperpigmentation | 2.00841201 |
| 18 | MP0003646_muscle_fatigue | 1.91471737 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.90776392 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.90085161 |
| 21 | MP0002102_abnormal_ear_morphology | 1.85984013 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 1.84434767 |
| 23 | MP0009745_abnormal_behavioral_response | 1.78631156 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.77933691 |
| 25 | MP0004142_abnormal_muscle_tone | 1.77405597 |
| 26 | MP0006292_abnormal_olfactory_placode | 1.71729546 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.71179413 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.70376961 |
| 29 | MP0002064_seizures | 1.69531161 |
| 30 | MP0002272_abnormal_nervous_system | 1.66285595 |
| 31 | MP0003123_paternal_imprinting | 1.65814685 |
| 32 | MP0009046_muscle_twitch | 1.64725022 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.61006558 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.59311757 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.59157685 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.58806000 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.57749009 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.57100990 |
| 39 | MP0000778_abnormal_nervous_system | 1.51721504 |
| 40 | MP0008872_abnormal_physiological_respon | 1.49804174 |
| 41 | MP0009697_abnormal_copulation | 1.49730780 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.49560162 |
| 43 | MP0002163_abnormal_gland_morphology | 1.49441877 |
| 44 | MP0004885_abnormal_endolymph | 1.44959478 |
| 45 | MP0005253_abnormal_eye_physiology | 1.44747249 |
| 46 | MP0003186_abnormal_redox_activity | 1.43103629 |
| 47 | MP0001764_abnormal_homeostasis | 1.40660402 |
| 48 | MP0001984_abnormal_olfaction | 1.40646806 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.40026740 |
| 50 | MP0004924_abnormal_behavior | 1.37322821 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.37322821 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.35158330 |
| 53 | MP0003122_maternal_imprinting | 1.32324440 |
| 54 | MP0003879_abnormal_hair_cell | 1.31869236 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.30665146 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.27795335 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.27493182 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.26992989 |
| 59 | MP0001970_abnormal_pain_threshold | 1.26939126 |
| 60 | MP0000427_abnormal_hair_cycle | 1.24542731 |
| 61 | MP0004742_abnormal_vestibular_system | 1.19594047 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.17630388 |
| 63 | MP0003011_delayed_dark_adaptation | 1.16930990 |
| 64 | MP0002063_abnormal_learning/memory/cond | 1.15774816 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.14992546 |
| 66 | MP0005310_abnormal_salivary_gland | 1.14347566 |
| 67 | MP0004147_increased_porphyrin_level | 1.10772642 |
| 68 | MP0002184_abnormal_innervation | 1.09443977 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.09409825 |
| 70 | MP0002229_neurodegeneration | 1.08535801 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.07920123 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.07627261 |
| 73 | MP0005408_hypopigmentation | 1.07352966 |
| 74 | MP0003633_abnormal_nervous_system | 1.07107216 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.06627947 |
| 76 | MP0002928_abnormal_bile_duct | 1.06587620 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.06142351 |
| 78 | MP0002882_abnormal_neuron_morphology | 1.05955315 |
| 79 | MP0003724_increased_susceptibility_to | 1.04530579 |
| 80 | MP0000955_abnormal_spinal_cord | 1.04426139 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 1.03826906 |
| 82 | MP0010094_abnormal_chromosome_stability | 1.01430337 |
| 83 | MP0004811_abnormal_neuron_physiology | 0.99432901 |
| 84 | MP0000538_abnormal_urinary_bladder | 0.99207569 |
| 85 | MP0008932_abnormal_embryonic_tissue | 0.97340952 |
| 86 | MP0008058_abnormal_DNA_repair | 0.97014207 |
| 87 | MP0008057_abnormal_DNA_replication | 0.95812999 |
| 88 | MP0003786_premature_aging | 0.95293844 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.95267496 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 0.94805872 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94455833 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.94290765 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.94052661 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.94035359 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.92704686 |
| 96 | MP0003868_abnormal_feces_composition | 0.91122078 |
| 97 | MP0008260_abnormal_autophagy | 0.90755747 |
| 98 | MP0003315_abnormal_perineum_morphology | 0.90244042 |
| 99 | MP0001119_abnormal_female_reproductive | 0.90218062 |
| 100 | MP0008995_early_reproductive_senescence | 0.89837506 |
| 101 | MP0001486_abnormal_startle_reflex | 0.89494406 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.88302318 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.87234869 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.87155175 |
| 105 | MP0001929_abnormal_gametogenesis | 0.87063260 |
| 106 | MP0001664_abnormal_digestion | 0.86672826 |
| 107 | MP0002139_abnormal_hepatobiliary_system | 0.86565976 |
| 108 | MP0004043_abnormal_pH_regulation | 0.85707999 |
| 109 | MP0005671_abnormal_response_to | 0.84566034 |
| 110 | MP0003631_nervous_system_phenotype | 0.83475143 |
| 111 | MP0008569_lethality_at_weaning | 0.83426121 |
| 112 | MP0003121_genomic_imprinting | 0.83098931 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.82878325 |
| 114 | MP0002090_abnormal_vision | 0.82540063 |
| 115 | MP0005266_abnormal_metabolism | 0.81693413 |
| 116 | MP0000372_irregular_coat_pigmentation | 0.81353381 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.79027082 |
| 118 | MP0005395_other_phenotype | 0.79024287 |
| 119 | MP0002822_catalepsy | 0.78747410 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.78524770 |
| 121 | MP0004133_heterotaxia | 0.78104121 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.78076626 |
| 123 | MP0003698_abnormal_male_reproductive | 0.77053146 |
| 124 | MP0002160_abnormal_reproductive_system | 0.76345101 |
| 125 | MP0005389_reproductive_system_phenotype | 0.75961082 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.75483123 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.75259640 |
| 128 | MP0005332_abnormal_amino_acid | 0.74922239 |
| 129 | MP0001963_abnormal_hearing_physiology | 0.74907255 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.74750290 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.74683784 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.73886942 |
| 133 | MP0000516_abnormal_urinary_system | 0.73886942 |
| 134 | MP0003077_abnormal_cell_cycle | 0.73666504 |
| 135 | MP0005499_abnormal_olfactory_system | 0.73448144 |
| 136 | MP0005394_taste/olfaction_phenotype | 0.73448144 |
| 137 | MP0000653_abnormal_sex_gland | 0.73214998 |
| 138 | MP0005535_abnormal_body_temperature | 0.72602900 |
| 139 | MP0000026_abnormal_inner_ear | 0.72587034 |
| 140 | MP0002751_abnormal_autonomic_nervous | 0.72497907 |
| 141 | MP0005195_abnormal_posterior_eye | 0.71658791 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.71415321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.32454749 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.90723067 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.54334242 |
| 4 | Acute encephalopathy (HP:0006846) | 5.25466926 |
| 5 | Progressive macrocephaly (HP:0004481) | 5.19514551 |
| 6 | Increased CSF lactate (HP:0002490) | 5.12267287 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.95675100 |
| 8 | Hepatic necrosis (HP:0002605) | 4.37969418 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.28732788 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.14383001 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.14383001 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 3.79225684 |
| 13 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.70906955 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.65064459 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 3.62919500 |
| 16 | Lactic acidosis (HP:0003128) | 3.54752138 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.54514809 |
| 18 | Cerebral edema (HP:0002181) | 3.50904671 |
| 19 | Increased serum lactate (HP:0002151) | 3.43280945 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.31763855 |
| 21 | Exercise intolerance (HP:0003546) | 3.26891716 |
| 22 | Respiratory failure (HP:0002878) | 3.20007472 |
| 23 | Optic disc pallor (HP:0000543) | 3.15123952 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.13284137 |
| 25 | Exertional dyspnea (HP:0002875) | 3.11719699 |
| 26 | Hypothermia (HP:0002045) | 3.05301362 |
| 27 | Nephronophthisis (HP:0000090) | 2.96668535 |
| 28 | Increased muscle lipid content (HP:0009058) | 2.90559393 |
| 29 | Respiratory difficulties (HP:0002880) | 2.87726832 |
| 30 | Focal seizures (HP:0007359) | 2.86810822 |
| 31 | Congenital stationary night blindness (HP:0007642) | 2.82016604 |
| 32 | Pancreatic fibrosis (HP:0100732) | 2.78412085 |
| 33 | Abnormal hair whorl (HP:0010721) | 2.74465016 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.71534508 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.70417479 |
| 36 | Leukodystrophy (HP:0002415) | 2.70367879 |
| 37 | Abnormality of the labia minora (HP:0012880) | 2.69425856 |
| 38 | Congenital primary aphakia (HP:0007707) | 2.63860497 |
| 39 | Focal motor seizures (HP:0011153) | 2.63607442 |
| 40 | Increased serum pyruvate (HP:0003542) | 2.61145521 |
| 41 | Abnormality of glycolysis (HP:0004366) | 2.61145521 |
| 42 | Poor suck (HP:0002033) | 2.60814857 |
| 43 | Dialeptic seizures (HP:0011146) | 2.60350573 |
| 44 | Gait imbalance (HP:0002141) | 2.59804259 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.58098741 |
| 46 | CNS demyelination (HP:0007305) | 2.52632173 |
| 47 | Abnormality of renal resorption (HP:0011038) | 2.50237231 |
| 48 | Broad-based gait (HP:0002136) | 2.49119577 |
| 49 | Microvesicular hepatic steatosis (HP:0001414) | 2.48848930 |
| 50 | Progressive inability to walk (HP:0002505) | 2.47880560 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.47358448 |
| 52 | Inability to walk (HP:0002540) | 2.47125586 |
| 53 | Type I transferrin isoform profile (HP:0003642) | 2.42345491 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.41838893 |
| 55 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.39699954 |
| 56 | Myokymia (HP:0002411) | 2.38002215 |
| 57 | Birth length less than 3rd percentile (HP:0003561) | 2.37989359 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 2.37556555 |
| 59 | Amyotrophic lateral sclerosis (HP:0007354) | 2.36405914 |
| 60 | Emotional lability (HP:0000712) | 2.35166310 |
| 61 | Type II lissencephaly (HP:0007260) | 2.32526170 |
| 62 | Unsteady gait (HP:0002317) | 2.32525514 |
| 63 | Lethargy (HP:0001254) | 2.31176897 |
| 64 | Absence seizures (HP:0002121) | 2.31090267 |
| 65 | Hemiparesis (HP:0001269) | 2.29399327 |
| 66 | Poor coordination (HP:0002370) | 2.29205465 |
| 67 | Lissencephaly (HP:0001339) | 2.27945933 |
| 68 | Glycosuria (HP:0003076) | 2.27201591 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.27201591 |
| 70 | Pancreatic cysts (HP:0001737) | 2.23812479 |
| 71 | Atonic seizures (HP:0010819) | 2.21525375 |
| 72 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.21471892 |
| 73 | Abnormality of alanine metabolism (HP:0010916) | 2.21471892 |
| 74 | Hyperalaninemia (HP:0003348) | 2.21471892 |
| 75 | True hermaphroditism (HP:0010459) | 2.19963963 |
| 76 | Renal cortical cysts (HP:0000803) | 2.18466929 |
| 77 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17875664 |
| 78 | Absent speech (HP:0001344) | 2.15610296 |
| 79 | Methylmalonic acidemia (HP:0002912) | 2.15415484 |
| 80 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.14021363 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.13524273 |
| 82 | Drooling (HP:0002307) | 2.13333525 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.13233916 |
| 84 | Cystic liver disease (HP:0006706) | 2.12539213 |
| 85 | Generalized tonic-clonic seizures (HP:0002069) | 2.11462939 |
| 86 | Oligomenorrhea (HP:0000876) | 2.11226997 |
| 87 | EEG with generalized epileptiform discharges (HP:0011198) | 2.10685778 |
| 88 | Abnormal pupillary function (HP:0007686) | 2.09985015 |
| 89 | Pachygyria (HP:0001302) | 2.04914018 |
| 90 | Limb dystonia (HP:0002451) | 2.03925760 |
| 91 | Hyperphosphaturia (HP:0003109) | 2.03036960 |
| 92 | Macrocytic anemia (HP:0001972) | 2.02769919 |
| 93 | Aplastic anemia (HP:0001915) | 2.02724692 |
| 94 | Specific learning disability (HP:0001328) | 2.01888913 |
| 95 | Breast hypoplasia (HP:0003187) | 2.01829032 |
| 96 | Agitation (HP:0000713) | 2.01586273 |
| 97 | Large for gestational age (HP:0001520) | 2.01413110 |
| 98 | Polydipsia (HP:0001959) | 2.01270394 |
| 99 | Abnormal drinking behavior (HP:0030082) | 2.01270394 |
| 100 | Methylmalonic aciduria (HP:0012120) | 2.00623882 |
| 101 | Attenuation of retinal blood vessels (HP:0007843) | 2.00430777 |
| 102 | Abnormal biliary tract physiology (HP:0012439) | 2.00141935 |
| 103 | Bile duct proliferation (HP:0001408) | 2.00141935 |
| 104 | Neuroendocrine neoplasm (HP:0100634) | 2.00018611 |
| 105 | Intestinal atresia (HP:0011100) | 1.98279121 |
| 106 | Chronic hepatic failure (HP:0100626) | 1.98147334 |
| 107 | Gliosis (HP:0002171) | 1.96393235 |
| 108 | Ketoacidosis (HP:0001993) | 1.95874762 |
| 109 | Excessive salivation (HP:0003781) | 1.95539064 |
| 110 | CNS hypomyelination (HP:0003429) | 1.94543535 |
| 111 | Abnormal eating behavior (HP:0100738) | 1.93944901 |
| 112 | Delusions (HP:0000746) | 1.93050190 |
| 113 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91821412 |
| 114 | Mutism (HP:0002300) | 1.91156178 |
| 115 | X-linked dominant inheritance (HP:0001423) | 1.90666311 |
| 116 | Dyskinesia (HP:0100660) | 1.86029958 |
| 117 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.83014889 |
| 118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.83014889 |
| 119 | Amniotic constriction ring (HP:0009775) | 1.83013783 |
| 120 | Abnormality of placental membranes (HP:0011409) | 1.83013783 |
| 121 | Sclerocornea (HP:0000647) | 1.82922627 |
| 122 | Postaxial hand polydactyly (HP:0001162) | 1.82539896 |
| 123 | Abnormality of macular pigmentation (HP:0008002) | 1.82024543 |
| 124 | Hyperventilation (HP:0002883) | 1.80273524 |
| 125 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.80126717 |
| 126 | Hypoplasia of the uterus (HP:0000013) | 1.79963225 |
| 127 | Polyphagia (HP:0002591) | 1.78870034 |
| 128 | Hyperglycinemia (HP:0002154) | 1.76929871 |
| 129 | Vaginal atresia (HP:0000148) | 1.76670147 |
| 130 | Genetic anticipation (HP:0003743) | 1.76282872 |
| 131 | Retinal dysplasia (HP:0007973) | 1.75498808 |
| 132 | Male pseudohermaphroditism (HP:0000037) | 1.75162531 |
| 133 | Genital tract atresia (HP:0001827) | 1.75115541 |
| 134 | Anencephaly (HP:0002323) | 1.74933439 |
| 135 | Cerebral hypomyelination (HP:0006808) | 1.74747855 |
| 136 | Abnormal protein glycosylation (HP:0012346) | 1.73808145 |
| 137 | Abnormal glycosylation (HP:0012345) | 1.73808145 |
| 138 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.73808145 |
| 139 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73808145 |
| 140 | Pheochromocytoma (HP:0002666) | 1.73013245 |
| 141 | Spastic tetraplegia (HP:0002510) | 1.71671034 |
| 142 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.70252583 |
| 143 | Optic nerve hypoplasia (HP:0000609) | 1.69095737 |
| 144 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.69018704 |
| 145 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.67663641 |
| 146 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66725112 |
| 147 | Narrow forehead (HP:0000341) | 1.66466599 |
| 148 | Febrile seizures (HP:0002373) | 1.66105776 |
| 149 | Ketosis (HP:0001946) | 1.65278877 |
| 150 | Generalized aminoaciduria (HP:0002909) | 1.64987023 |
| 151 | Renal tubular dysfunction (HP:0000124) | 1.64055066 |
| 152 | Abnormality of the axillary hair (HP:0100134) | 1.63492024 |
| 153 | Abnormality of secondary sexual hair (HP:0009888) | 1.63492024 |
| 154 | Epileptic encephalopathy (HP:0200134) | 1.61101547 |
| 155 | Secondary amenorrhea (HP:0000869) | 1.59563702 |
| 156 | Pallor (HP:0000980) | 1.58855512 |
| 157 | Reticulocytopenia (HP:0001896) | 1.58526603 |
| 158 | Abnormality of midbrain morphology (HP:0002418) | 1.58440050 |
| 159 | Molar tooth sign on MRI (HP:0002419) | 1.58440050 |
| 160 | Carpal bone hypoplasia (HP:0001498) | 1.57726831 |
| 161 | Premature ovarian failure (HP:0008209) | 1.57657725 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.57253335 |
| 163 | Cholecystitis (HP:0001082) | 1.57253335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.63358233 |
| 2 | MAP3K12 | 3.99994756 |
| 3 | MAP2K7 | 3.25768765 |
| 4 | CASK | 3.25187312 |
| 5 | BUB1 | 3.20473450 |
| 6 | MARK1 | 2.68111942 |
| 7 | MAP4K2 | 2.67402980 |
| 8 | MUSK | 2.57123823 |
| 9 | STK16 | 2.47654401 |
| 10 | NME1 | 2.34404864 |
| 11 | ARAF | 2.27805133 |
| 12 | MAP3K4 | 2.19887389 |
| 13 | CDK8 | 2.02146481 |
| 14 | TSSK6 | 1.98621598 |
| 15 | TRIM28 | 1.96783767 |
| 16 | BRAF | 1.93296388 |
| 17 | NUAK1 | 1.93207777 |
| 18 | PLK4 | 1.92554378 |
| 19 | TNIK | 1.86313104 |
| 20 | VRK1 | 1.77236403 |
| 21 | BMPR2 | 1.76885881 |
| 22 | WEE1 | 1.75563908 |
| 23 | AKT3 | 1.74497684 |
| 24 | NME2 | 1.67273157 |
| 25 | CDK19 | 1.64994536 |
| 26 | GRK7 | 1.63422802 |
| 27 | ERBB4 | 1.56262424 |
| 28 | ADRBK2 | 1.55416911 |
| 29 | DAPK2 | 1.55085007 |
| 30 | EIF2AK3 | 1.52824670 |
| 31 | PAK3 | 1.52289684 |
| 32 | CCNB1 | 1.48708463 |
| 33 | MAP3K6 | 1.48579923 |
| 34 | ACVR1B | 1.43405299 |
| 35 | GRK5 | 1.43119819 |
| 36 | BCKDK | 1.40945261 |
| 37 | BMPR1B | 1.38942471 |
| 38 | MOS | 1.36809407 |
| 39 | MYLK | 1.36457903 |
| 40 | NTRK2 | 1.32171063 |
| 41 | SRPK1 | 1.30754140 |
| 42 | STK38L | 1.30304727 |
| 43 | IRAK3 | 1.29006292 |
| 44 | TAOK3 | 1.23494393 |
| 45 | MAP2K4 | 1.20802174 |
| 46 | ERBB3 | 1.18342107 |
| 47 | MAPKAPK5 | 1.16271229 |
| 48 | PHKG1 | 1.13967321 |
| 49 | PHKG2 | 1.13967321 |
| 50 | NTRK3 | 1.12578411 |
| 51 | FGFR2 | 1.11222457 |
| 52 | CSNK1A1L | 1.10798397 |
| 53 | PRKCE | 1.08190642 |
| 54 | EPHA3 | 1.07558302 |
| 55 | MINK1 | 1.05896118 |
| 56 | MAPK13 | 1.03867825 |
| 57 | PLK2 | 1.00626157 |
| 58 | BRSK2 | 0.98909405 |
| 59 | MST4 | 0.96266746 |
| 60 | EIF2AK1 | 0.94377395 |
| 61 | SIK2 | 0.94035287 |
| 62 | KIT | 0.93811416 |
| 63 | DAPK1 | 0.93386084 |
| 64 | OXSR1 | 0.92148347 |
| 65 | PLK1 | 0.91141140 |
| 66 | INSRR | 0.91104724 |
| 67 | CSNK1G3 | 0.89140049 |
| 68 | RAF1 | 0.86756611 |
| 69 | PLK3 | 0.85614427 |
| 70 | DYRK2 | 0.84477014 |
| 71 | TLK1 | 0.84217653 |
| 72 | CAMK2A | 0.79474416 |
| 73 | CDK3 | 0.77360106 |
| 74 | PINK1 | 0.74548587 |
| 75 | SIK3 | 0.73540626 |
| 76 | AURKA | 0.71017045 |
| 77 | MAP3K13 | 0.68748224 |
| 78 | PNCK | 0.68143989 |
| 79 | WNK3 | 0.68048449 |
| 80 | TEC | 0.67907771 |
| 81 | CSNK1G1 | 0.65847171 |
| 82 | EPHA4 | 0.65794181 |
| 83 | CDK5 | 0.65197966 |
| 84 | STK39 | 0.64973430 |
| 85 | MAP3K9 | 0.64726639 |
| 86 | ZAK | 0.64552030 |
| 87 | PRKCG | 0.64219380 |
| 88 | PBK | 0.64075911 |
| 89 | PKN1 | 0.63908447 |
| 90 | CSNK1G2 | 0.63700627 |
| 91 | UHMK1 | 0.62878960 |
| 92 | DYRK1A | 0.62808468 |
| 93 | ADRBK1 | 0.62686938 |
| 94 | IRAK4 | 0.62088853 |
| 95 | BRSK1 | 0.62012815 |
| 96 | PAK6 | 0.62001776 |
| 97 | ABL2 | 0.57397233 |
| 98 | PIM2 | 0.56249115 |
| 99 | CSNK2A1 | 0.54513484 |
| 100 | CAMK2G | 0.53915786 |
| 101 | TTK | 0.53611285 |
| 102 | PDK3 | 0.51780400 |
| 103 | PDK4 | 0.51780400 |
| 104 | PRKCQ | 0.51590696 |
| 105 | CAMK1 | 0.50922186 |
| 106 | GRK1 | 0.50527458 |
| 107 | CHEK2 | 0.50512641 |
| 108 | STK11 | 0.49909612 |
| 109 | PRKCZ | 0.48070792 |
| 110 | PDK2 | 0.47957357 |
| 111 | TXK | 0.47515991 |
| 112 | LIMK1 | 0.47373583 |
| 113 | TYK2 | 0.46867009 |
| 114 | MAP2K6 | 0.46166706 |
| 115 | RPS6KA5 | 0.46006142 |
| 116 | SGK2 | 0.45717779 |
| 117 | CAMK2B | 0.45116791 |
| 118 | LATS2 | 0.44049022 |
| 119 | SGK223 | 0.43580386 |
| 120 | SGK494 | 0.43580386 |
| 121 | CSNK2A2 | 0.42955021 |
| 122 | CSNK1D | 0.41619735 |
| 123 | PIK3CA | 0.41176558 |
| 124 | CSNK1A1 | 0.40987897 |
| 125 | IRAK1 | 0.40519118 |
| 126 | BCR | 0.39661962 |
| 127 | TNK2 | 0.39352747 |
| 128 | CAMKK2 | 0.38909586 |
| 129 | MAPKAPK3 | 0.38697012 |
| 130 | PTK2B | 0.37567935 |
| 131 | PRKAA1 | 0.37390301 |
| 132 | RIPK4 | 0.37339783 |
| 133 | NEK6 | 0.37337938 |
| 134 | CAMKK1 | 0.37195607 |
| 135 | BRD4 | 0.37151214 |
| 136 | PRKG1 | 0.35903695 |
| 137 | SYK | 0.35319195 |
| 138 | PRKCI | 0.34980622 |
| 139 | CDC7 | 0.33277199 |
| 140 | MKNK2 | 0.32696645 |
| 141 | IKBKE | 0.32543422 |
| 142 | WNK4 | 0.32154638 |
| 143 | PRKACA | 0.30530817 |
| 144 | CAMK2D | 0.30219113 |
| 145 | PRKCA | 0.29908324 |
| 146 | CAMK4 | 0.29899988 |
| 147 | PRKACB | 0.28005605 |
| 148 | FES | 0.27953555 |
| 149 | AURKB | 0.27638766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.32771941 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.28871751 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.64163119 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.27320741 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.25094654 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.11760959 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 3.11178125 |
| 8 | Protein export_Homo sapiens_hsa03060 | 3.10020838 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.77143210 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.47319423 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.98468541 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.95948438 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.70050639 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63554915 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.62805765 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 1.61394948 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60921441 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.56335655 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50427904 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49071649 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.48295235 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.46029190 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38988509 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.37987171 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.37799319 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.36698260 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.35788430 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35745056 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.30473425 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24012127 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23135133 |
| 32 | DNA replication_Homo sapiens_hsa03030 | 1.22139099 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21638996 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17301403 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13687569 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12019807 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09094696 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.08566996 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08511098 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07102179 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04873481 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.04537423 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01222285 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 0.99341435 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 0.98591908 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98561559 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98163334 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92787792 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.92734307 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 0.90043774 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 0.89029118 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.88576481 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87380292 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85660467 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85215941 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84095634 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83877160 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82571900 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82439577 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80490370 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.80206543 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80063550 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79811759 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78107195 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.75595095 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73025357 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.72809875 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.71998612 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71695959 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70129633 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69479755 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68930759 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68650722 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67591994 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.64747543 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64213316 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63429032 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63370967 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62160873 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61501789 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61227596 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60703061 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60181073 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57631020 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57172315 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56656002 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55748313 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55696042 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55630931 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52741847 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52343980 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50787013 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50423910 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49917897 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49490672 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48951933 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48658362 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.47942156 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47171551 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46744383 |
| 101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45001404 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44822926 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.43104474 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42975394 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42971025 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42428016 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42425248 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41589074 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40515882 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39928330 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39271629 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.37329521 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37281171 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36972932 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36798060 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36599496 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36585227 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36062724 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36009166 |
| 120 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35459139 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34540523 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.32690298 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31507436 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31056006 |
| 125 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30769120 |
| 126 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.28518917 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28501799 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.28476588 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28041573 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27938622 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26143204 |
| 132 | Insulin secretion_Homo sapiens_hsa04911 | 0.26125202 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24572946 |
| 134 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24495454 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24183190 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22908918 |
| 137 | Allograft rejection_Homo sapiens_hsa05330 | 0.22464034 |
| 138 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21277177 |

